VN Research & Consulting
 Like us on facebook  Follow us on twitter  Follow us on LinkedIn  IndiaNotes on Google Plus  IndiaNotes on Pinterest  IndiaNotes on Stumbleupon  Subscribe to our feeds

Stocks  A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
You are here : IndiaNotes >> Research & Analysis >> Companies >> Dishman Pharmaceuticals & Chemicals Ltd. >> Research

Dishman: A Healthy Multibagger

Dynamic Equities Pvt Ltd | 25 Jan, 2017  | Follow Author | Add to my Favourites 
  • Rate this article
    (Average Rating 1.0 Based on 1 ratings)

Dishman pharmaceuticals and chemicals is a multinational company which was incorporated in 1983 and became a public company with effect from 1st April 1996. Dishman is engaged in manufacturing of active ingredients for the pharmaceutical industry.

Earnings Per Share (EPS) is considered the most important indicator of a company’s stock value and profitability.

We can see that the EPS is increasing over the subsequent years and the percentage change has also been tremendous, which is a very good sign. Even in the Quarter on Quarter (QoQ) result the EPS has increased from 0.52 (July 2016) to Rs.2.34 (September 2016) which is a percentage change of 361%.

Annual revenue helps in determining the health of the business.

We see that the annual revenue is increasing annually but the percentage change has remained quite flat from 2015 to 2016. Other than that we have seen a tremendous jump in the annual revenue over the past 4 years.

Latest news, new products & announcement of the company

July 2016 – Dishman Pharmaceuticals and Chemicals got the US Food and Drug Administration's clearance for its Naroda facility in Gujarat and its Neuland facilities in Switzerland.

Shareholding pattern of a stock is very important. A stock which has low supply and high demand creates an environment for the stock to go high. It is good if the company acquire its own stock.

In Dishman

It is also important to know the number of institutions holding a company’s stock. 776 institutions are holding the company’s stock.

Some of the Institutions are:

Thus, we can see that a good number of institutions are holding the shares of the company and the promoters are also holding a good percentage of shares. This is a very healthy sign for the company’s stock.

It is important to choose the leaders over laggards; this is decided by seeing the stock performance of the company. Dishman has also performed with its peers and the stock has given a return of 54.68%.


Dishman has support at Rs.196 which is its 3 month low. Upside target for this stock is at Rs.261.7 (2 week high). Dishman share price is currently trading at Rs.229 one can enter at buy position at Rs.220 – 224.

Key points from management

Management is focusing more on the CRAMS, disinfectant and vitamin D3 segments. They believe that the HiPo API, niche generic API and disinfectants will be the main future growth drivers. They have invested in new instruments to help in undertaking more complex research and projects.

  Read full report Click here to read the full report

301.05 +8.40
301.20 +0.00
Read More
About Dynamic Equities Pvt Ltd

Dynamic Equities Pvt. Ltd. is a a SEBI Registered Investment Advisor and Stock Broker, a leading financial services provider, and one of the major players in the Equity markets in India. With an experience of over 15+ years in Stock Markets and Equity Research, they provide daily updated Support & Resistance of 4200 instruments across 93 exchanges and 56 countries globally. They have an in-house team of over 25 analysts. Under the guidance and mentorship of Mr. Shailesh Saraf, MD of Dynamic Equities Pvt. Ltd., these analysts are dedicately involved in guiding their clients and users of the website for trading in the market. Mr. Shailesh Saraf has an experience of over 24 years in the financial market, especially in capital & derivatives market operations, trading, research and management related areas. Dynamic Levels is a website owned by Dynamic Equities Pvt. Ltd. The website can be reached at

For more information please write in to [email protected]

Disclaimer: The author has taken due care and caution to compile and analyse the data. The opinions expressed above are only the views of the author, and not a recommendation to buy or sell. Neither the author nor accept any liability whatsoever arising from the use of any of the above contents.

Technical Calls

What are technical calls?

Other Articles